immagine del profilo
Instead of $PFE, I would rather take $JNJ for the medical sector and I would not do smaller than 1000€ per position - I would rather do only one position per sector before too many small positions fill the portfolio.
immagine del profilo
@Dividenden-Sammler all right, thanks for the tip. Why would you prefer Johnson?
immagine del profilo
@user88b8e3cfdd1c4e20 When I think of $PFE, I immediately think of the Corona vaccine and how the company profited from it. I just see problems in the future when the preparation is no longer needed in the masses, a sales problem. I don't see how the company can compensate for this in any other way. In my opinion, $JNJ is better positioned and, for me, the leading company in the industry. I would also prefer $NOVN, $ABBV or $NOVO B to Pfizer. I would rather keep my hands off the corona profiteers.
1
immagine del profilo
@Dividenden-Sammler Thank you for your assessment. I can understand that very well. What do you think about the price level of $JNJ and $NOVO B? JNJ says more there with a look at the recent price?
immagine del profilo
@user88b8e3cfdd1c4e20 yes $NOVO B has run well - but I think there is still potential. $JNJ is the big dino and you can certainly see that as a basic investment. I myself have decided for $JNJ and continue to expand my position. $NOVN I also hold a position in my 2nd depot - just more difficult to increase further, because monthly not parsable or also not at every broker to obtain. I would rather keep my hands off ADRs.
1
immagine del profilo
@Dividenden-Sammler thank you for sharing
1